Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/1999
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994294 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
11/30/1999US5993490 Composition for the oxidation dyeing of keratin fibers containing a cationic direct dye and dyeing process using this composition
11/30/1999CA2179011C 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
11/26/1999CA2272838A1 Oxydation dye composition for keratin fibers and dyeing process using said composition
11/25/1999WO1999059990A1 Pyridyl-pyrazole derivatives, process for their preparation, and their use as herbicides
11/25/1999WO1999059979A1 Substituted pyridine and pyrimidines, processes for their preparation and their use as pesticides
11/25/1999WO1999059974A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors
11/25/1999WO1999059972A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
11/25/1999WO1999059971A1 Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
11/25/1999WO1999059961A1 Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions
11/25/1999WO1999059591A1 Pyrazinone thrombin inhibitors
11/25/1999WO1999059581A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999WO1999059570A1 Protease inhibitors
11/25/1999WO1999059529A2 Agents and method for producing semi-permanent colorations of keratin fibers
11/25/1999WO1999059526A2 Protease inhibitors
11/25/1999WO1999059499A2 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1999047517A8 Novel heterocyclic compounds
11/25/1999WO1999040068A3 2-aminoquinoline derivatives having d4-agonistic activity
11/25/1999DE3943678C2 New isoquinoline:sulphonamide and naphthalene:sulphonamide cpds.
11/25/1999CA2332531A1 Protease inhibitors
11/25/1999CA2332505A1 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999CA2332492A1 Protease inhibitors
11/25/1999CA2332316A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors
11/25/1999CA2329914A1 Pyrazinone thrombin inhibitors
11/25/1999CA2329530A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999CA2272831A1 Hair dyeing composition for keratin fibres containing a direct cationic colorant and a polymer
11/24/1999EP0959076A1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999EP0959075A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999EP0959074A2 Substituted pyrazoles as CRF antagonists
11/24/1999EP0959073A1 Sulfonamide derivative and process for preparing the same
11/24/1999EP0959072A1 Sulfonamide derivative and process for preparing the same
11/24/1999EP0958292A1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
11/24/1999EP0958290A1 1,4-dihydropyridin derivatives and their use in therapy
11/24/1999EP0958287A1 Sulfamide-metalloprotease inhibitors
11/24/1999EP0958282A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
11/24/1999EP0957917A1 Vitronectin receptor antagonists
11/24/1999EP0957913A1 N-linked sulfonamides of heterocyclic thioesters
11/24/1999EP0575503B1 Herbicidal pyridine sulfonamide
11/24/1999CN1236365A Substituted benzocycloheptapyridine useful as inhibitors of Farnesyl protein transferase
11/24/1999CN1236364A Substituted benzocycloheptapyridine derivatives useful for inhibition of Farnesyl protein transferase
11/24/1999CN1236361A N-substituted 2-cyanopyrodlidines
11/24/1999CN1236358A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
11/24/1999CN1235826A 10, 11 methanodibenzosuberane derivatives used as chemosensitizing agents
11/24/1999CN1046718C 6-(2-imidzolinylamino) quinoline compounds useful as alpha-2-adrenoceptor agonists
11/24/1999CN1046715C Process for making HIV protease inhibitors
11/24/1999CN1046713C Tetrahydroisoquinoline compound, pharmaceutical composition containing them and its producing method and use
11/24/1999CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/24/1999CN1046710C aminopyridines, process for preparing the same and use and medicaments containing the same
11/23/1999US5990314 Pharmaceutical pyridine compounds
11/23/1999US5990311 Producing 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl)-1,2,3,4 -tetrahydroisoquinolin-2-yl)pyrimidine by condensing 5,6-dimethyl-2-(4-fluorophenylamino)pyrimidine with 1-methyl-1,2,3,4-tetrahydroisoquinoline
11/23/1999US5990150 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
11/23/1999US5990148 Side effect reductions; antiarthritic agents; nonsteroidal antiinflammatory agents
11/23/1999US5990144 Treating parkinson's disease, tourette's syndrome, schizophrenia, and alcohol and drug addiction; dopaminergic properties; side-effect reduction
11/23/1999US5990139 Thiazolidinedione derivatives or salts thereof and pharmaceutical compositions containing the same
11/23/1999US5990133 Indole derivatives as 5-HT receptor antagonist
11/23/1999US5990132 Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
11/23/1999US5990131 Heterocyclic thioesters and ketones
11/23/1999US5990130 Therapeutic heterocycles
11/23/1999US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor
11/23/1999US5990126 Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
11/23/1999US5990122 Substituted in the 7-position by a tricyclic amine radical; reduced genotoxic properties and increased antibacterial activity
11/23/1999US5990112 6-mercaptomethyl-piperazin-2,5-dione derivatives; useful for treating or controlling disease states or conditions which involve tissue breakdown, such as rheumatoid arthritis
11/23/1999US5990106 Antibiotics; 3-azabicyclo(3.2.0)hept-3-yl group joined at given position of a pyridonecarboxylic acid residue, such as 7-(1-amino-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6,8-difluoro-1,4 -dihydro-4-oxoquinoline-3-carboxylic acid
11/23/1999US5990105 Possess a selective affinity to 5ht-6 receptors; treating or preventing psychoses, schizophrenia, manic depressions, depressions, neurological disorders, parkinson's, amyotrophic lateral sclerosis, alzheimer's and huntington's disease
11/23/1999US5990089 Introducing a polynucleotide into a eukaryotic cell in a living animal comprising contacting the cell with a composition comprising a polynucleotide and a dendrimer polycation coupled to the polynucleotide
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058526A1 Novel 2,5-pyridinedicarboxylic acid derivatives
11/18/1999WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058506A1 N,n'-azobis-nitroazoles and analogs thereof as igniter compounds for use in energetic compositions
11/18/1999WO1999058503A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058501A1 Compounds with growth hormone releasing properties
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058487A1 New compounds, their preparation and use
11/18/1999WO1999058486A1 New compounds, their preparation and use
11/18/1999WO1999058162A2 Pharmaceuticals for the imaging of angiogenic disorders
11/18/1999WO1999058128A1 Inhibition of protein kinases with piridinylimidazoles
11/18/1999WO1999050255A3 Disubstituted pyrazolines and triazolines as factor xa inhibitors
11/18/1999DE19822198A1 Permanent colorant for keratin fibers, especially for coloring human hair
11/18/1999DE19821002A1 New indazole derivatives useful as antiasthmatic, antiallergic, neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2327386A1 Inhibition of protein kinases with piridinylimidazoles
11/18/1999CA2324555A1 Pharmaceuticals for the imaging of angiogenic disorders
11/17/1999EP0957109A2 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
11/17/1999EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/17/1999EP0957100A1 Diamine derivatives and pharmaceutical containing the same
11/17/1999EP0957093A2 Retrovial protease inhibitors
11/17/1999EP0957092A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
11/17/1999EP0956865A1 MEDICINES COMPRISING Rho KINASE INHIBITOR
11/17/1999EP0956857A2 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
11/17/1999EP0956297A1 Chiral peptide nucleic acids
11/17/1999EP0956018A1 Imidazole compounds, compositions and use